...
首页> 外文期刊>Chemical Weekly >Ranbaxy,Aurobindo,Hetero applauded by UN Secretary-General for expanding access to HIV treatment
【24h】

Ranbaxy,Aurobindo,Hetero applauded by UN Secretary-General for expanding access to HIV treatment

机译:联合国秘书长赞扬奥罗宾多·兰巴西,扩大获得艾滋病毒治疗的机会

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ranbaxy Laboratories and Hydera-bad-based Aurobinda Pharma and Hetero Drugs were among some of the world's leading pharmaceutical and diagnostic companies applauded by UN Secretary-General,Dr.Kofi Annan for their commitment to expand access to HIV/AIDS treatment and prevention.Mr.Annan complimented these companies for their efforts in the field of HIV/AIDS treatment and prevention,after a meeting with their top executives at United Nations headquarters.
机译:Ranbaxy实验室和总部设在海德拉巴的Aurobinda Pharma和Hetero Drugs是联合国秘书长科菲·安南博士称赞的全球领先制药和诊断公司之一,他们对扩大获得艾滋病毒/艾滋病治疗和预防的承诺表示赞赏。 。安南在联合国总部与高管会晤后,赞扬这些公司在艾滋病毒/艾滋病治疗和预防领域所做的努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号